Cargando…
Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis
BACKGROUND AND PURPOSE: This study was undertaken to determine the diagnostic and prognostic value of a panel of serum biomarkers and to correlate their concentrations with several clinical parameters in a large cohort of patients with amyotrophic lateral sclerosis (ALS). METHODS: One hundred forty‐...
Autores principales: | Falzone, Yuri Matteo, Domi, Teuta, Mandelli, Alessandra, Pozzi, Laura, Schito, Paride, Russo, Tommaso, Barbieri, Alessandra, Fazio, Raffaella, Volontè, Maria Antonietta, Magnani, Giuseppe, Del Carro, Ubaldo, Carrera, Paola, Malaspina, Andrea, Agosta, Federica, Quattrini, Angelo, Furlan, Roberto, Filippi, Massimo, Riva, Nilo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314044/ https://www.ncbi.nlm.nih.gov/pubmed/35263489 http://dx.doi.org/10.1111/ene.15321 |
Ejemplares similares
-
Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease
por: Falzone, Yuri Matteo, et al.
Publicado: (2020) -
NEK1 Variants in a Cohort of Italian Patients With Amyotrophic Lateral Sclerosis
por: Riva, Nilo, et al.
Publicado: (2022) -
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double‐blind, placebo‐controlled trial
por: Beghi, Ettore, et al.
Publicado: (2022) -
Amyotrophic lateral sclerosis: a clinical review
por: Masrori, P., et al.
Publicado: (2020) -
Cortical inexcitability defines an adverse clinical profile in amyotrophic lateral sclerosis
por: Dharmadasa, T., et al.
Publicado: (2020)